(Reuters) - Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by distributors and said the problems would persist in the ...
Medtronic (NYSE:MDT) traded lower in pre-market hours Tuesday, down 4.54% to $88.60 as of 08:20 AM ET, despite reaffirming its full-year guidance alongside its Q3 FY25 results. The MedTech giant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback